
Tuesday, November 29, 2022 2:48:36 AM
Organigram reports Q4 results; issues FY23 soft guidance
Nov. 29, 2022 OrganiGram Holdings Inc. (OGI),
Organigram press release (NASDAQ:OGI):
Q4 net loss was $6.1M, compared to a net loss of $26.0M in Q4 Fiscal 2021.
Adjusted EBITDA of $3.2M, the third consecutive quarter of positive Adjusted EBITDA, compared to negative Adjusted EBITDA of $4.8M in the same prior year period.
Adjusted Gross Margin of $10.4M or 23%, compared to $3.0M or 12% in the same prior year period, reflecting improvements from increased efficiencies and higher sales volume.
Revenue of $45.5M (+82.7% Y/Y) beats by $13.45M.
Outlook: Organigram currently expects Fiscal 2023 revenue to be higher than that of Fiscal 2022.
The company expects to see an improvement in adjusted gross margins in Fiscal 2023 and has put measures in place that it expects will further improve margins over time.
The company expects significant growth in Adjusted EBITDA in Fiscal 2023 over Fiscal 2022.
The company expects to have positive cash flows from operating activities during Fiscal 2023 and positive free cash flows during calendar 2023.
https://seekingalpha.com/news/3911764-organigram-reports-q4-results-issues-fy23-soft-guidance?mailingid=29829239&messageid=2900&serial=29829239.64&utm_campaign=rta-stock-news&utm_content=link-1&utm_medium=email&utm_source=seeking_alpha&utm_term=29829239.64

Liked By
Spread the love. Be the first to like this post!
Recent OGI News
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 01/26/2023 04:18:49 PM
- Organigram Provides NASDAQ Listing Update • Business Wire • 01/26/2023 11:00:00 AM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 01/12/2023 12:47:58 PM
- Organigram Reports Record First Quarter Fiscal 2023 Results • Business Wire • 01/12/2023 11:00:00 AM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 01/05/2023 02:53:51 PM
- Organigram to Report First Quarter Fiscal 2023 Results on January 12, 2023 • Business Wire • 01/05/2023 11:00:00 AM
- Voluntary Supplemental Material Filed Pursuant to Section 11(a) of the Securities Act of 1933 by Foreign Issuers (suppl) • Edgar (US Regulatory) • 12/19/2022 04:25:43 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 12/09/2022 02:54:27 PM
- Organigram Wins KIND Magazine’s Cannabis Company of the Year Award and Most Innovative Product of the Year for Edison JOLTS • Business Wire • 12/08/2022 11:00:00 AM
- Three Reasons It’s Time To Get Bullish On Organigram • ValueWalk • 11/29/2022 11:51:33 PM
- Organigram Reports Record Fourth Quarter and Full Year Fiscal 2022 Results • Business Wire • 11/29/2022 01:00:00 AM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 11/23/2022 06:28:57 PM
- Organigram Launches HOLY MOUNTAIN to Further Support Its Strong Position in the Dried Flower and Hash Categories • Business Wire • 11/23/2022 11:00:00 AM
- High Tide Becomes Top Revenue-Generating Cannabis Company in Canada • PR Newswire (US) • 11/22/2022 11:00:00 AM
- High Tide Becomes Top Revenue-Generating Cannabis Company in Canada • PR Newswire (Canada) • 11/22/2022 11:00:00 AM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 11/18/2022 01:22:51 PM
- Organigram to Report Annual Fiscal 2022 Results on November 28, 2022 • Business Wire • 11/18/2022 01:00:00 AM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 11/17/2022 06:45:02 PM
- Organigram and Intercure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies • GlobeNewswire Inc. • 11/17/2022 01:17:09 PM
- Organigram and InterCure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies • Business Wire • 11/17/2022 01:00:00 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 07/14/2022 04:23:01 PM
- Organigram Reports Third Quarter Fiscal 2022 Results • Business Wire • 07/14/2022 10:00:00 AM
- Organigram to Report Third Quarter 2022 Results on July 14, 2022 • Business Wire • 07/09/2022 12:00:00 AM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 06/24/2022 05:42:09 PM
- Proposed Settlement Reached in 2016 Class Action • Business Wire • 06/24/2022 12:00:00 AM
1606 Corp Now Trading under Ticker CBDW, Management Announces First Acquisition • CBDW • Jan 27, 2023 11:59 AM
IQST - iQSTEL Reminds Shareholders To Get Their Votes In Before Annual Meeting Next Week On January 31, 2023 • IQST • Jan 26, 2023 9:53 AM
Nextech AR's AI-Powered CAD to Poly Toggle3D Launches Major Technology Advancements • ARWYF • Jan 26, 2023 8:46 AM
UCASU jump-starts its plan of NASDAQ or NYSE up-listing in 2023 • UCASU • Jan 26, 2023 7:21 AM
Kaya Holdings, Inc. (OTCQB: KAYS) Launches Fifth Dimension Therapeutics™ to seek to Provide Innovative Psychedelic-Based Treatments for Depression and Anxiety Related Conditions and Address the Growing Multi-Billion Dollar Global Psychedelics Market • KAYS • Jan 25, 2023 10:53 AM
B2 Digital's B2 SPORTS NETWORK (B2SN) Expands Distribution to Europe, Russia, and Asia with StayLIVE Agreement • BTDG • Jan 25, 2023 10:00 AM